www.fdanews.com/articles/150128-qrxpharma-announces-strategic-collaboration-with-paladin-labs

QRxPharma Announces Strategic Collaboration With Paladin Labs

October 10, 2012

QRxPharma announced execution of a licensing agreement with Paladin Labs for the Canadian commercialization rights to MOXDUO, a patented, immediate release formulation of morphine and oxycodone.
The Herald